The single-use bioprocessing market size is USD 20.2 Bn in 2026.
The single-use bioprocessing market is projected to grow at a CAGR of 13% by 2033.
The market growth is driven by flexibility over stainless steel systems, lower cleaning and validation costs, and rising demand for biologics, vaccines, and cell & gene therapies.
North America is the dominating region for the single-use bioprocessing market.
Thermo Fisher Scientific, Sartorius AG, Danaher Corporation, Merck KGaA, and Pall Corporation are some of the leading industry players in the single-use bioprocessing market.